HADASSAH SHADROUZ: Open Payments
NPI 1083251953 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,539 in 17 payments from 11 companies in 2025. Trend: 2023 $229 · 2024 $928 · 2025 $1,539
Food & beverage: $1,539
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $264 |
| Lilly USA, LLC | 2 | $250 |
| LNHC, Inc | 2 | $152 |
| Amgen Inc. | 1 | $150 |
| PFIZER INC. | 2 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $140 |
| GENZYME CORPORATION | 1 | $136 |
| Verona Pharma, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Exact Sciences Corporation | 2 | $37 |
Products named: ZELSUVMI, OTEZLA, Kerendia, DUPIXENT, Ohtuvayre, Auvelity, Ozempic, MOUNJARO.
Industry payments across NY — which companies pay providers there.
